CureVac to Present at the 12th International mRNA Health Conference

November 4, 2024 7:15 AM

TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / November 4, 2024 / CureVac N.V. (Nasdaq:CVAC) ("CureVac"), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mRNA"), today announced that new and updated data will be shared in two oral presentations and four posters at the 12th International mRNA Health Conference, taking place in Boston, Massachusetts, November 12-14,...

Read more

NLS Pharmaceutics and Kadimastem Enter into a Definitive Merger Agreement

November 4, 2024 7:00 AM

ZURICH, SWITZERLAND and NESS ZIONA, ISRAEL / ACCESSWIRE / November 4, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP) ("NLS"), a biopharmaceutical company, and Kadimastem Ltd. (TASE: KDST.TA") ("Kadimastem"), a clinical-stage cell therapy company developing and manufacturing "off-the-shelf" allogeneic cell products for the treatment of neurodegenerative diseases and potential cure of diabetes, announced today that they have entered into a definitive...

Read more

Global Disposable Negative Pressure Wound Therapy Devices Market Projected to Reach USD 529.7 Million by 2034 | Future Market Insights, Inc.

November 4, 2024 6:00 AM

The global sales of disposable negative pressure wound therapy devices are on track to reach an estimated value of USD 529.7 million by 2034, up from USD 287.5 million in 2024, according to recent market analysis. This growth represents a compound annual growth rate (CAGR) of 6.3% during the forecast period from 2024 to 2034.In 2023, the disposable NPWT devices market generated USD 270.5 million in revenue, reflecting a steady demand for...

Read more

Relief Therapeutics Signs Non-Binding Letter of Intent with Renexxion for Reverse Merger

November 4, 2024 1:20 AM

RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today announced it has signed a non-binding letter of intent (LOI) with Renexxion, Inc. (Renexxion), a privately-held U.S.-based clinical-stage biotechnology company specializing in gastrointestinal disorders therapies. The...

Read more

NanoViricides to Provide Corporate Update at the Spartan Capital Investors Conference 2024, Today at 9:45am

November 4, 2024 12:00 AM

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage global leader in broad-spectrum antiviral nanomedicines, today announces that Anil R. Diwan, Ph.D., the Company's President and Executive Chairman, will be presenting a corporate update at the Spartan Capital Investors Conference on Monday, November 4, 2024 (today) at 9:45 am. The Conference will be held at the Pierre Hotel in New York City.EventThe Spartan Capital...

Read more

State of Latinos in Georgia Report to Unveil Key Findings on November 19 in Norcross

November 1, 2024 4:30 PM

Economic Development, Education, Housing & Safety Nets, Healthcare, Arts & Culture, and Political Power are the six areas covered in the report, the first of its kind in GeorgiaATLANTA, GA / ACCESSWIRE / November 1, 2024 / A seminal report outlining the realities, challenges, contributions, and opportunities of the Latino community in Georgia is scheduled to be unveiled at the 10th Annual Latino Summit on November 19 at the Norcross Cultural...

Read more

Innovex International, Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call

November 1, 2024 4:00 PM

Innovex International, Inc. (NYSE:INVX), (the "Company" or "Innovex") announced today that it will release its third quarter 2024 earnings results on November 7, 2024, after the close of the U.S. financial markets.Management will host a conference call and a webcast to discuss the financial results on November 8, 2024, at 10:00 a.m. Eastern Daylight Time / 9:00 a.m. Central Daylight Time. The presentation is open to all interested parties and...

Read more

Cosmos Health's Subsidiary CosmoFarm Achieves Record Revenue, Up 8.62% to $43 Million YTD 2024, with Gross Profit Rising 21%

November 1, 2024 12:30 PM

CHICAGO, IL / ACCESSWIRE / November 1, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that its healthcare distribution business, operated through its wholly...

Read more

Biofrontera Inc. to Report Third Quarter Financial Results on November 13, 2024

November 1, 2024 11:55 AM

WOBURN, MA / ACCESSWIRE / November 1, 2024 / Biofrontera Inc. (Nasdaq:BFRI) ("Biofrontera" or the "Company"), a biopharmaceutical company specializing in the development and commercialization of PDT, announces it will report financial results for the three and nine months ended September 30, 2024 on Wednesday, November 13, 2024. The results will be released after the market close on Wednesday, Nov 13 and the company will host a conference call...

Read more

UnisLink Earns HITRUST I1 Certification to Manage Data Protection and Mitigate Cybersecurity Threats

November 1, 2024 11:00 AM

HITRUST certification validates that UnisLink is operating with leading security practices to protect sensitive information.PHOENIX, AZ / ACCESSWIRE / November 1, 2024 / UnisLink, a leading provider of full-service revenue cycle management solutions, announced that its multiple facilities and platforms have earned certified status by HITRUST for information security.UnisLink Platforms Earning HITRUST i1 Certification:RCM SmartLink residing at...

Read more

CNS Pharmaceuticals Granted Exception by Nasdaq to Regain Compliance with Minimum Bid Price Requirement

November 1, 2024 9:00 AM

HOUSTON, TX / ACCESSWIRE / November 1, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that on October 30, 2024, it received notice from The Nasdaq Hearings Panel that the Company has been granted an exception until March 11, 2025, to regain compliance...

Read more

Nation's Largest Pancreatic Cancer Early Detection Study Holds Annual Meeting in San Diego

November 1, 2024 9:00 AM

PRECEDE Study Aims to Increase Early Detection in Pancreatic CancerSAN DIEGO, CA / ACCESSWIRE / November 1, 2024 / Pancreatic cancer has the lowest five-year survival rate of all major cancers at a shockingly low 13%, and it is the third leading cause of cancer mortality in the United States. The need for early detection of pancreatic cancer through enhanced screening tools is vital, as pancreatic cancer is often detected at the latest stages...

Read more

Invitation to Presentation of Cantargia’s Interim Report January - September 2024

November 1, 2024 5:20 AM

LUND, SE / ACCESSWIRE / November 01, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm:CANTA) invites investors, analysts and the press to a presentation of the interim report for January - September 2024 at 3 pm (CET) on November 15, 2024. The report will be published at 07:00 am (CET) the same day.In conjunction to the report, Cantargia invites investors, analysts, and media to an audiocast with teleconference (in English)...

Read more

iZafe Group Q3 Interim Report, July-September 2024

November 1, 2024 3:50 AM

STOCKHOLM, SE / ACCESSWIRE / November 01, 2024 / iZafe Group (STO:IZAFE-B) iZafe Group AB (publ.) presents today, November 1, its report for the third quarter.Financial Performance in SummaryTotal revenue for the quarter amounted to 2,434 (927) TSEK, an organic growth approximately 2.5 times higher than the corresponding quarter of the previous year.The operating result (EBIT) for the quarter amounted to -4,148 (-5,012) TSEK.The operating profit...

Read more

Javid Javdani Calls for Increased Support for Small Business Owners in California

October 31, 2024 9:15 PM

Javid Javdani, owner of Balboa Market in San Diego, is raising awareness about the importance of supporting small businesses, particularly international food markets, as essential cultural and community resources. His business, Balboa Market, has become a gathering space where food fosters connection and cultural exchange. Javdani's unique perspective as an immigrant and entrepreneur has underscored the critical need for small business support,...

Read more

Dr. Jay Woody Honored for Decade of Service to ACEP Freestanding Emergency Center Section

October 31, 2024 5:05 PM

PLANO, TX / ACCESSWIRE / October 31, 2024 / Dr. Jay Woody, MD, FACEP, the founder and chief medical officer of Intuitive Health, has been recognized for his exceptional contributions to the field of freestanding emergency medicine by the American College of Emergency Physicians (ACEP) Freestanding Emergency Center Section. The award was presented during the ACEP24 Scientific Assembly.Dr. Woody was honored for his decade-long dedication to the...

Read more

Verisante Technology, Inc. Announces Update to Proposed RTO with SunRegen Healthcare AG

October 31, 2024 5:05 PM

Verisante Technology, Inc. (TSXV:VER.H) ("Verisante") is pleased to announce a transaction update further to it's initial news release dated August 12, 2024, that it has entered into a binding Letter of Intent ("LOI") to acquire a 100% interest in SunRegen Healthcare AG ("SunRegen"), a Swiss pharmaceutical company. The proposed transaction is a Reverse Takeover ("RTO") pursuant to Policy 5.2 of the TSX Venture Exchange and the resulting issuer...

Read more

Veterans Bridge Home and 704 Shop Partner to Support Charlotte Veterans

October 31, 2024 5:00 PM

CHARLOTTE, NC / ACCESSWIRE / October 31, 2024 / Veterans Bridge Home (VBH), a leading non-profit organization dedicated to connecting, leading and advocating for veterans and their families across the Carolinas, recently announced a partnership with 704 Shop, a lifestyle brand in Charlotte. This collaboration introduces a limited-edition line of apparel designed to raise funds for VBH's programs that assist local veterans during their transition...

Read more

Bloom Health Centers Expands Comprehensive Mental Health Services in Winchester, VA

October 31, 2024 4:02 PM

Bloom Health Centers is thrilled to announce the expansion of its therapy services in Winchester, Virginia. With this development, Bloom Health Center now offers a comprehensive range of mental health services, including psychiatry, Transcranial Magnetic Stimulation (TMS), and therapy, both in person and virtually.For the past five years, Tamara McDaniel, PA-C, has been a cornerstone of the psychiatric and medication management services in the...

Read more

Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf

October 31, 2024 4:01 PM

BOULDER, CO / ACCESSWIRE / October 31, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn ® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye, oral and nasal care, dermatological conditions, podiatry, and animal health care, today announced that it will be exhibiting at MEDICA 2024 in Düsseldorf, Germany...

Read more